Privium Fund Management B.V. / ARWR
Privium Fund Management B.V.’s Arrowhead Pharmaceuticals In Position
Does Privium Fund Management B.V. own Arrowhead Pharmaceuticals In (ARWR)? Yes — 366.9K shares worth $23M (+4.79% of its 13F portfolio) as of Q1 2026, down from 398.2K shares the prior filed quarter.
Position Value
$23M
Q1 2026
Shares
366.9K
% of Portfolio
+4.79%
Quarters Held
18
currently held
Position History ARWR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 366.9K | $23M | +4.79% |
| Q4 2025 | 398.2K | $26M | +4.87% |
| Q3 2025 | 474.0K | $16M | +2.94% |
| Q2 2025 | 612.2K | $10M | +2.13% |
| Q1 2025 | 629.2K | $8M | +2.09% |
| Q4 2024 | 380.6K | $7M | +1.62% |
| Q3 2024 | 333.4K | $6M | +1.61% |
| Q2 2024 | 286.9K | $7M | +1.85% |
| Q1 2024 | 273.9K | $8M | +2.09% |
| Q4 2023 | 273.9K | $8M | +2.37% |
| Q3 2023 | 259.0K | $7M | +2.07% |
| Q2 2023 | 259.0K | $9M | +2.68% |
| Q1 2023 | 259.0K | $7M | +2.21% |
| Q4 2022 | 221.0K | $9M | +3.36% |
| Q3 2022 | 175.4K | $6M | +2.12% |
| Q2 2022 | 175.4K | $6M | +2.05% |
| Q1 2022 | 182.7K | $8M | +1.86% |
| Q4 2021 | 204.4K | $14M | +2.73% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of ARWR.